1.
Yuan X, Liu Y, Zhang T, Xia J, Lan X, Pan Q, Han M. The prognostic difference study on the individualized clopidogrel administration in Hmong and Dong patients based on the CYP2C19 gene polymorphism after percutaneous coronary intervention: Gene-based clopidogrel admin in Hmong and Dong PCI. Cell Mol Biol (Noisy-le-grand) [Internet]. 2024 Sep. 8 [cited 2025 Mar. 15];70(8):110-5. Available from: https://cellmolbiol.org/index.php/CMB/article/view/5628